PROCEPT BioRobotics Corporation Increase (Decrease) in Other Operating Liabilities
PROCEPT BioRobotics Corporation (PRCT) reported Increase (Decrease) in Other Operating Liabilities of $1.97 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInOtherOperatingLiabilities · last filed 2026-08-05
- PROCEPT BioRobotics Corporation increase (decrease) in other operating liabilities for the quarter ending 2026-06-30 was $1.79M, a 52.95% increase year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in other operating liabilities for the quarter ending 2026-03-31 was $180.00K, a 53.85% decline year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in other operating liabilities for the quarter ending 2025-12-31 was $1.83M, a 846.63% increase year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in other operating liabilities for the quarter ending 2025-09-30 was -$1.52M, a 1134.01% decline year-over-year.
- PROCEPT BioRobotics Corporation increase (decrease) in other operating liabilities for fiscal 2025 was $1.87M, a 5.48% increase from fiscal 2024.
- PROCEPT BioRobotics Corporation increase (decrease) in other operating liabilities for fiscal 2024 was $1.77M.
- PROCEPT BioRobotics Corporation increase (decrease) in other operating liabilities for fiscal 2023 was -$1.15M, a 143.21% decline from fiscal 2022.
- PROCEPT BioRobotics Corporation increase (decrease) in other operating liabilities for fiscal 2022 was $2.66M, a 7.26% increase from fiscal 2021.
| Period end | Increase (Decrease) in Other Operating Liabilities 3 month | Increase (Decrease) in Other Operating Liabilities 6 month | Increase (Decrease) in Other Operating Liabilities 9 month | Increase (Decrease) in Other Operating Liabilities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $1.79M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.97M 10-Q · filed 2026-08-05 | $3.80M derived: sum of 3 quarters · filed 2026-08-05 | $2.28M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $180.00K 10-Q · filed 2026-04-30 | $2.01M derived: sum of 2 quarters · filed 2026-04-30 | $487.00K derived: sum of 3 quarters · filed 2026-04-30 | $1.66M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $1.83M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $307.00K derived: sum of 2 quarters · filed 2026-02-26 | $1.48M derived: sum of 3 quarters · filed 2026-08-05 | $1.87M 10-K · filed 2026-02-26 |
| 2025-09-30 | -$1.52M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | -$349.00K derived: sum of 2 quarters · filed 2026-08-05 | $41.00K 10-Q · filed 2025-11-05 | $234.00K derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $1.17M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $1.56M 10-Q · filed 2026-08-05 | $1.75M derived: sum of 3 quarters · filed 2026-08-05 | $1.90M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $390.00K 10-Q · filed 2026-04-30 | $583.00K derived: sum of 2 quarters · filed 2026-04-30 | $730.00K derived: sum of 3 quarters · filed 2026-04-30 | $855.00K derived: sum of 4 quarters · filed 2026-04-30 |
| 2024-12-31 | $193.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $340.00K derived: sum of 2 quarters · filed 2026-02-26 | $465.00K derived: sum of 3 quarters · filed 2026-02-26 | $1.77M 10-K · filed 2026-02-26 |
| 2024-09-30 | $147.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-05 | $272.00K derived: sum of 2 quarters · filed 2025-11-05 | $1.58M 10-Q · filed 2025-11-05 | $110.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $125.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-07 | $1.43M 10-Q · filed 2025-08-07 | -$37.00K derived: sum of 3 quarters · filed 2026-02-26 | -$1.14M derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $1.31M 10-Q · filed 2025-05-02 | -$162.00K derived: sum of 2 quarters · filed 2026-02-26 | -$1.27M derived: sum of 3 quarters · filed 2026-02-26 | -$189.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | -$1.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | -$2.57M derived: sum of 2 quarters · filed 2026-02-26 | -$1.50M derived: sum of 3 quarters · filed 2026-02-26 | -$1.15M 10-K · filed 2026-02-26 |
| 2023-09-30 | -$1.10M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-28 | -$27.00K derived: sum of 2 quarters · filed 2024-10-28 | $319.00K 10-Q · filed 2024-10-28 | $1.66M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-02 | $1.42M 10-Q · filed 2024-08-02 | $2.76M derived: sum of 3 quarters · filed 2025-02-27 | $4.43M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $346.00K 10-Q · filed 2024-05-02 | $1.68M derived: sum of 2 quarters · filed 2025-02-27 | $3.35M derived: sum of 3 quarters · filed 2025-02-27 | $3.62M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $1.34M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $3.00M derived: sum of 2 quarters · filed 2025-02-27 | $3.27M derived: sum of 3 quarters · filed 2025-02-27 | $2.66M 10-K · filed 2025-02-27 |
| 2022-09-30 | $1.67M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-02 | $1.93M derived: sum of 2 quarters · filed 2023-11-02 | $1.32M 10-Q · filed 2023-11-02 | $3.09M derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-06-30 | $267.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-07-28 | -$346.00K 10-Q · filed 2023-07-28 | $1.43M derived: sum of 3 quarters · filed 2024-02-28 | $443.00K derived: sum of 4 quarters · filed 2024-02-28 |
| 2022-03-31 | -$613.00K 10-Q · filed 2023-05-04 | $1.16M derived: sum of 2 quarters · filed 2024-02-28 | $176.00K derived: sum of 3 quarters · filed 2024-02-28 | $1.49M derived: sum of 4 quarters · filed 2024-02-28 |
| 2021-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-28 | $789.00K derived: sum of 2 quarters · filed 2024-02-28 | $2.10M derived: sum of 3 quarters · filed 2024-02-28 | $2.48M 10-K · filed 2024-02-28 |
| 2021-09-30 | -$983.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-04 | $326.00K derived: sum of 2 quarters · filed 2022-11-04 | $707.00K 10-Q · filed 2022-11-04 | $1.58M derived: sum of 4 quarters · filed 2022-11-04 |
| 2021-06-30 | $1.31M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-05 | $1.69M 10-Q · filed 2022-08-05 | $2.56M derived: sum of 3 quarters · filed 2022-08-05 | |
| 2021-03-31 | $381.00K 10-Q · filed 2022-05-06 | $1.25M derived: sum of 2 quarters · filed 2022-05-06 | ||
| 2020-12-31 | $871.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-22 | $199.00K 10-K · filed 2022-03-22 | ||
| 2020-09-30 | -$672.00K 10-Q · filed 2021-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |
| ANGIODYNAMICS INC (ANGO) | United States | $0.632B | -13.02 |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B |